Medidata Study Experience

  1. Accelerate Approval Of Novel Therapies 8/9/2023

    Learn how to make critical, data-driven decisions throughout the product development lifecycle and increase new therapies' probability of success.

  2. Fast Data Insights Improve Productivity, Client Centricity 7/20/2023

    Discover how Medidata's Rave CTMS seamlessly met the comprehensive requirements of Catalyst Clinical Research—an exclusive CRO provider specializing in oncology—during a period of rapid expansion.

  3. Validating New Identification Algorithms With Objective Criteria & Clinical Trial Data 7/19/2023

    Learn how researchers and clinicians can make better-informed decisions to advance patient care and enhance public health outcomes related to myocardial infarction.

  4. Shorten The Path: From Discovery To Approval Of Novel Therapies 6/19/2023

    Unearth how this trial design solution was able to utilize historical trial data and real-life examples across different indications throughout the clinical development process in five case studies.

  5. Improving CAR-T Trial Success With Historical Trial Data Optimization 6/19/2023

    Breakthroughs in oncology have revolutionized patient care. Dive into treatment access, challenges faced in clinical development, and how data can be utilized to accelerate clinical development.

  6. Big Roadblocks To Avoid When Implementing A New CTMS 6/9/2023

    Watch as presenters from Medidata dive into the most common roadblocks customers face when adopting a modern CTMS—and how to avoid them.

  7. Achieving Diversity In Clinical Trials Amidst Regulatory Focus 5/23/2023

    Learn about several strategies and best practices when enhancing diversity in clinical trials and advancing healthcare for all ethnic groups.

  8. New Research On Concurrence Of CRS & ICANS In CAR T-cell Treatments 5/23/2023

    Gain insight into the latest advancements in AI-driven investigations, shedding light on the complexities of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapies.

  9. Enhancing Clinical Trials By Linking Them To RWD 5/16/2023

    Learn how integrating participant trial data and real-world data into a standard EDC system can promote success in obtaining IRB approval.

  10. Linking Clinical Trial Data With Real-World Data: Q&A With HealthVerity 5/16/2023

    Director of Partners and Alliance Management at HealthVerity KC Ahlberg discusses some key trends related to the use of real-world data in clinical trials, and the value sponsors are realizing through data linkage.